Publications
Preprints and pre-reviewed scientific papers about SARS-COV-2 seroprevalence studies.
Sero-prevalence findings from metropoles in Pakistan: implications for assessing COVID-19 prevalence and case-fatality within a dense, urban working population
Population-level serologic testing has demonstrated groundbreaking results in monitoring the prevalence and case-fatality of COVID-19 within a population.
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults
England, UK has experienced a large outbreak of SARS-CoV-2 infection.
SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region
The objective of this study was to perform a large seroprevalence survey on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among Danish healthcare workers to identify high risk groups.
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England
We investigated six London care homes experiencing a COVID-19 outbreak and found very high rates of SARS-CoV-2 infection among residents and staff.
Covid-19 serology in nephrology health care workers
Chronic kidney disease patients show a high mortality in case of a SARS-CoV-2 infection.
Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study
The number of confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Japan are substantially lower in comparison to the US and UK, potentially due to the under-implementation of polymerase chain reaction (PCR) tests.
SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study
SARS-CoV-2 has driven a pandemic crisis. Serological surveys have been conducted to establish prevalence for covid-19 antibody in various cohorts and communities. However, the prevalence among healthcare workers is still being analyzed.
SARS-CoV-2 serosurvey in Health Care Workers of the Veneto Region
The ongoing outbreak of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses formidable challenges to all health care systems.
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
Community-level seroprevalence surveys are needed to determine the proportion of the population with previous SARS-CoV-2 infection, a necessary component of COVID-19 disease surveillance.
Humoral Response Dynamics Following Infection with SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) specific antibodies have been shown to neutralize the virus in-vitro.
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Qatar has a population of 2.8 million, over half of whom are expatriate craft and manual workers (CMW).
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates
School closures are part of the SARS-CoV-2 pandemic control measures in many countries, based on the assumption that children play a similar role in transmitting SARS-CoV-2 as they do in transmitting influenza.
Overview of SARS-COV-2 studies seroprevalence in context of the worldwide COVID-19 pandemie. You can register a study here: Contribute
serohub@helmholtz-hzi.de
@serohub on Twitter
hzi-braunschweig/serohub on GitHub